Activity value 71united states Buyer,Last transaction date:
2026-07-18Address: 4580 S MENDENHALL ROAD MEMPHIS TN 38141
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for sagent c o eversana life science s from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 8 transactions, with a transaction quantity of 115 and a transaction weight of 56483.22.
YearTransactionsQuantityWeight
202512391149
2026811556483.22
Bill of lading data
<
1/9
>
Trade date
2026/07/18
B/L No.
zimugoa10918651
Suppliers
corden pharma s.p.a.
Buyers
sagent c o eversana life science s
POLs
47094, valencia
PODs
1703, savannah, ga
Supply area
Italy
Purchas area
United States
Weight
12674.94kg
Amount
——
Hs code
Product tags
propofol
Product description
PROPOFOL Expand
Trade date
2026/06/07
B/L No.
chsl549635968can
Suppliers
qilu pharmaceutical hainan co.ltd.
Buyers
sagent c o eversana life science s
Product description
DECITABINE FOR INJECTION 50MG BORTEZOMIB FOR INJECTION 3.5MG PEMETREXED FOR INJECTION 100MG TEMPERATURE SET AT 22.0 C 71.6 F Expand
Trade date
2026/06/05
B/L No.
zimugoa10909271
Suppliers
corden pharma s.p.a.
Buyers
sagent c o eversana life science s
POLs
47527, genoa
PODs
1703, savannah, ga
Supply area
Italy
Purchas area
United States
Weight
10098.04kg
Amount
——
Hs code
Product tags
propofol
Product description
PROPOFOL Expand
Trade date
2026/06/05
B/L No.
zimugoa10909291
Suppliers
corden pharma s.p.a.
Buyers
sagent c o eversana life science s
POLs
47527, genoa
PODs
1703, savannah, ga
Supply area
Italy
Purchas area
United States
Weight
9196.29kg
Amount
——
Hs code
Product tags
propofol
Product description
PROPOFOL Expand
Trade date
2026/05/14
B/L No.
chsl546934865can
Suppliers
qilu pharmaceutical hainan co.ltd.
Buyers
sagent c o eversana life science s
sagent c o eversana life science s is united states Buyer,
and primarily engages in the import and export business of products such as cyclophosphamide,for injection.
According to the 52wmb.com global trade database, as of 2026-07-18, the company has completed 9 international trades,
with its main trading regions covering italy,china etc.
The core products include HS848041 etc,
often transported via 1703, savannah, ga etc,
and its main trading partners are corden pharma s.p.a.,qilu pharmaceutical hainan co.ltd.,ningbo shuangcheng pharmaceuticals.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on sagent c o eversana life science s is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.